⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL834242 | 1.00 | — | — | |
| SCHEMBL161162 | 1.00 | — | — | |
| SCHEMBL3764002 | 0.96 | — | — | |
| SCHEMBL581266 | 0.76 | — | — | |
| SCHEMBL581267 | 0.76 | — | — | |
| SCHEMBL316478 | 0.76 | — | — | |
| SCHEMBL851233 | 0.76 | — | — | |
| SCHEMBL130885 | 0.76 | — | — | |
| SCHEMBL25023638 | 0.72 | ALDH1A1 (0.44) | — | |
| SCHEMBL611581 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6734209-B2 | MACROCYCLIC LACTONES HAVING ANTI-CANCER ACTIVITY AND VACUOLAR ATPASE INHIBITORY ACTIVITY | BOARD OF REGENTS THE UNIVERSITY OF TEXAS SYSTEM | 2004-05-11 | — | — | US | claimed |
| US-20040063778-A1 | Synthetic salicylihalamides, apicularens and derivatives thereof | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2004-04-01 | — | — | US | claimed |
| US-6617348-B1 | Treating or preventing osteoporosis | UT SOUTHWESTERN MEDICAL CENTER | 2003-09-09 | — | — | US | claimed |
| EP-1307439-A2 | SYNTHETIC SALICYLIHALAMIDES, APICULARENS AND DERIVATIVES THEREOF | Board of Regents, The University of Texas System (US) | 2003-05-07 | — | — | EP | claimed |
| WO-2002012223-A2 | SYNTHETIC SALICYLIHALAMIDES, APICULARENS AND DERIVATIVES THEREOF | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2002-02-14 | — | — | WO | claimed |
| EP-1944307-A2 | Synthetic Salicylihalamides, Apicularens and Derivatives Thereof | Board of Regents, The University of Texas System (US) | 2008-07-16 | — | — | EP | disclosed |
| US-20060116390-A1 | Hepatitis c virus inhibitors | LG LIFE SCIENCES LTD. (KR) | 2006-06-01 | — | — | US | disclosed |
| EP-1633725-A1 | HEPATITIS C VIRUS INHIBITORS | LG Life Sciences Ltd. (KR) | 2006-03-15 | — | — | EP | disclosed |
| US-6936723-B2 | Synthetic salicylihalamides, apicularens and derivatives thereof | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2005-08-30 | — | — | US | disclosed |
| WO-2004111013-A1 | HEPATITIS C VIRUS INHIBITORS | LG LIFE SCIENCES LTD. (KR) | 2004-12-23 | — | — | WO | disclosed |
| US-20040171672-A1 | Synthetic salicylihalamides, apicularens and derivatives thereof | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2004-09-02 | — | — | US | disclosed |
| US-6734209-B2 | MACROCYCLIC LACTONES HAVING ANTI-CANCER ACTIVITY AND VACUOLAR ATPASE INHIBITORY ACTIVITY | BOARD OF REGENTS THE UNIVERSITY OF TEXAS SYSTEM | 2004-05-11 | — | — | US | disclosed |
| WO-2002012223-A2 | SYNTHETIC SALICYLIHALAMIDES, APICULARENS AND DERIVATIVES THEREOF | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2002-02-14 | — | — | WO | disclosed |
| EP-0863866-B1 | BUTYRATE PRODRUGS OF LACTIC ACID | VERTEX PHARMA (US) | 2001-05-02 | — | — | EP | disclosed |
| US-6225350-B1 | ADMINISTERING BUTYRATE PRODRUG FOR THERAPY OF CYSTIC FIBROSIS | VERTEX PHARMACEUTICALS, INC. | 2001-05-01 | — | — | US | disclosed |
| US-5912269-A | SICKLE CELL SYNDROME, ANTICARCIOGENIC AGENTS | VERTEX PHARMACEUTICALS, INC. (US) | 1999-06-15 | — | — | US | disclosed |
| US-5883123-A | GAMMA GLOBIN AND FETAL HEMOGLOBIN, SICKLE CELL SYNDROME AND THALASSEMIA SYNDROME | VERTEX PHARMACEUTICALS, INC. (US) | 1999-03-16 | — | — | US | disclosed |
| US-5880152-A | INFLAMMATORY BOWEL DISEASE | VERTEX PHARMACEUTICALS, INC. (US) | 1999-03-09 | — | — | US | disclosed |
| EP-0863866-A1 | BUTYRATE PRODRUGS OF LACTIC ACID | Vertex Pharmaceuticals Incorporated (US) | 1998-09-16 | — | — | EP | disclosed |
| WO-1997012855-A1 | BUTYRATE PRODRUGS OF LACTIC ACID | VERTEX PHARMACEUTICALS INCORPORATED (US) | 1997-04-10 | — | — | WO | disclosed |